CAS 206884-98-2

Niraxostat

CAS : 206884-98-2

Niraxostat

Degré de pureté : ≥98%

Masse moléculaire : 299.32g/mol

Ref: 54-BUP02715

Niraxostat

CAS : 206884-98-2

Niraxostat is a mannosidase inhibitor that has inhibitory properties against the enzyme mannosidase. It is used to treat squamous cell carcinoma, which can be caused by excessive production of alpha-mannosidase. Niraxostat also inhibits the production of proinflammatory cytokines and other inflammatory mediators, such as prostaglandin E2 and nitric oxide. This inhibition may promote tumor regression by controlling inflammation. The mechanism of action is not fully understood, but may involve the inhibition of protein kinase C or phospholipases.

Formule : C₁₆H₁₇N₃O₃

Degré de pureté : Min. 95%

Masse moléculaire : 299.32 g/mol

Ref: 3D-GIA88498

Niraxostat

CAS : 206884-98-2

Niraxostat (Y-700) is one of the isocytosine derivatives as xanthine oxidase inhibitors.

Formule : C₁₆H₁₇N₃O₃

Degré de pureté : 98.13%

Couleur et forme : Solid

Masse moléculaire : 299.32

Ref: TM-T33676